Pulse nav.journalClub Debates activos Tendencias Explorar Investigadores

Download the App

Join discussions, follow papers, and never miss your next session.

Download on theApp Store

© Synapse Social LLC, 2026

Política de privacidad

Inicio Explorar nav.journalClub Tendencias

⌘+K

Comparing predictors of conversion and decline in mild cognitive impairment | Synapse

July 1, 2010Open Access

Comparing predictors of conversion and decline in mild cognitive impairment

Puntos clave

Los puntos clave no están disponibles para este artículo en este momento.

Resumen

Baseline FDG-PET and episodic memory predict conversion to AD, whereas p-tau(181p)/Abeta(1-42) and, marginally, FDG-PET predict longitudinal cognitive decline. Complementary information provided by these biomarkers may aid in future selection of patients for clinical trials or identification of patients likely to benefit from a therapeutic intervention.

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Preguntar a la IA

Me gusta

Guardar

Compartir

Ver artículo completo

Cite This Study

Landau et al. (Thu,) studied this question.

synapsesocial.com/papers/69d787dbb1cb92dd1bb8b8a9 https://doi.org/https://doi.org/10.1212/wnl.0b013e3181e8e8b8

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Conceptual Overview2003 · 29 citations
2Rate of cognitive change in Alzheimer's disease: Methodological approaches using random effects models2001 · 30 citations
3Update on the biomarker core of the Alzheimer's Disease Neuroimaging Initiative subjects2010 · 314 citations
4MRI and CSF biomarkers in normal, MCI, and AD subjects2009 · 394 citations
5Hippocampal and entorhinal atrophy in mild cognitive impairment2007 · 757 citations